Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

New Elite Feature: Find Similar Charts in Seconds

Mangoceuticals, Inc.

Contributing Author

Recent Articles by Mangoceuticals, Inc.

Aug-13	Mangoceuticals Inc.'s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets MGRX GlobeNewswire
Aug-06	Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure MGRX +23.85% GlobeNewswire
Aug-05	Mangoceuticals' Merger Partner, Nuclea Energy ("Nuclea"), Executes MOU with Utah Office of Energy Development MGRX -7.10% GlobeNewswire
Aug-04	Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination MGRX -14.55% GlobeNewswire
Jul-30	Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology MGRX -46.88% GlobeNewswire
Mar-17	Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. MGRX MGRX -6.95% GlobeNewswire
Mar-06	Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds MGRX MGRX -7.02% GlobeNewswire
Feb-23	Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study MGRX GlobeNewswire
Feb-19	MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program MGRX MGRX +48.83% GlobeNewswire
Dec-19	Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements MGRX -45.57% GlobeNewswire
Dec-19	Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy MGRX -45.57% GlobeNewswire
Dec-18	Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules MGRX +7.38% GlobeNewswire
Nov-13	Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs MGRX +24.37% GlobeNewswire
Nov-13	Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management MGRX -32.39% GlobeNewswire
May-27	Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu MGRX +11.83% GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)